Pascal and Francis Bibliographic Databases


Search results

Your search

kw.\*:("Inhibidor proteasome")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 920

  • Page / 37

Selection :

  • and

An Historic Perspective of Proteasome InhibitionESSELTINE, Dixie-Lee; MULLIGAN, George.Seminars in hematology. 2012, Vol 49, Num 3, pp 196-206, issn 0037-1963, 11 p.Article

Discovery and Development of Second-Generation Proteasome InhibitorsKIRK, Christopher J.Seminars in hematology. 2012, Vol 49, Num 3, pp 207-214, issn 0037-1963, 8 p.Article

Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome InhibitionEVERLY, Matthew J; TERASAKI, Paul I; HOPFIELD, Judy et al.Transplantation. 2010, Vol 90, Num 12, pp 1493-1498, issn 0041-1337, 6 p.Conference Paper

Proteasome Inhibitors as Immunosuppressants: Biological Rationale and Clinical ExperienceMORAN, Eva; CARBONE, Federico; AUGUSTI, Valeria et al.Seminars in hematology. 2012, Vol 49, Num 3, pp 270-276, issn 0037-1963, 7 p.Article

Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5α B-box 2 domainDIAZ-GRIFFERO, Felipe; KAR, Alak; PERRON, Michel et al.Journal of virology. 2007, Vol 81, Num 19, pp 10362-10378, issn 0022-538X, 17 p.Article

Proteasome Inhibitors and Bone DiseaseQIANG, Ya-Wei; HEUCK, Christoph J; SHAUGHNESSY, John D et al.Seminars in hematology. 2012, Vol 49, Num 3, pp 243-248, issn 0037-1963, 6 p.Article

PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitorZHAO, Wei-Li; LIU, Yan-Yan; SHEN, Zhi-Xiang et al.Blood. 2008, Vol 111, Num 7, pp 3867-3871, issn 0006-4971, 5 p.Article

Antitumor activity of PR-171, a novel irreversible inhibitor of the proteasomeDEMO, Susan D; KIRK, Christopher J; SHENK, Kevin D et al.Cancer research (Baltimore). 2007, Vol 67, Num 13, pp 6383-6391, issn 0008-5472, 9 p.Article

Durability of Antibody Removal Following Proteasome Inhibitor-Based TherapyEVERLY, Matthew J; TERASAKI, Paul I; TRIVEDI, Hargovind L et al.Transplantation. 2012, Vol 93, Num 6, pp 572-577, issn 0041-1337, 6 p.Article

Proteasome Inhibitors in Cancer Therapy : Lessons from the First Decade : The development of new cytotoxic agents in clinical oncologyORLOWSKI, Robert Z; KUHN, Deborah J.Clinical cancer research. 2008, Vol 14, Num 6, pp 1649-1657, issn 1078-0432, 9 p.Article

The Impact of Proteasome Inhibition on Alloantibody-Producing Plasma Cells In VivoDIWAN, Tayyab S; RAGHAVAIAH, Suresh; BURNS, Justin M et al.Transplantation. 2011, Vol 91, Num 5, pp 536-541, issn 0041-1337, 6 p.Article

12/13 inhibition enhances the anticancer effect of bortezomib through PSMB5 downregulationYOON MEE YANG; LEE, Sanghwan; CHANG WON NAM et al.Carcinogenesis (New York. Print). 2010, Vol 31, Num 7, pp 1230-1237, issn 0143-3334, 8 p.Article

Broad-Spectrum Antimalarial Activity of Peptido Sulfonyl Fluorides, a New Class of Proteasome InhibitorsTSCHAN, Serena; BROUWER, Arwin J; MORDMÜLLER, Benjamin et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 8, pp 3576-3584, issn 0066-4804, 9 p.Article

Novel Proteasome Inhibitors to Overcome Bortezomib ResistanceRUSCHAK, Amy M; SLASSI, Malik; KAY, Lewis E et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 13, pp 1007-1017, issn 0027-8874, 11 p.Article

Selective Induction of Expression of a Ligand for the NKG2D Receptor by Proteasome InhibitorsVALES-GOMEZ, Mar; CHISHOLM, Susan E; CASSADY-CAIN, Robin L et al.Cancer research (Baltimore). 2008, Vol 68, Num 5, pp 1546-1554, issn 0008-5472, 9 p.Article

Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibitionJINSONG HU; NANA DANG; MENU, Eline et al.Blood. 2012, Vol 119, Num 3, pp 826-837, issn 0006-4971, 12 p.Article

High Basal Nuclear Levels of Nrf2 in Acute Myeloid Leukemia Reduces Sensitivity to Proteasome InhibitorsRUSHWORTH, Stuart A; BOWLES, Kristian M; MACEWAN, David J et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 5, pp 1999-2009, issn 0008-5472, 11 p.Article

The Proteasome Inhibitor Epoxomicin Has Potent Plasmodium falciparum Gametocytocidal ActivityCZESNY, Beata; GOSHU, Samrawit; COOK, James L et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 10, pp 4080-4085, issn 0066-4804, 6 p.Article

Inhibitors of the proteasome suppress homologous DNA recombination in mammalian cellsMURAKAWA, Yasuhiro; SONODA, Eiichiro; BOULTON, Simon J et al.Cancer research (Baltimore). 2007, Vol 67, Num 18, pp 8536-8543, issn 0008-5472, 8 p.Article

Proteasome Inhibition for Antibody-Mediated Allograft RejectionSADAKA, Basma; ALLOWAY, Rita R; SHIELDS, Adele R et al.Seminars in hematology. 2012, Vol 49, Num 3, pp 263-269, issn 0037-1963, 7 p.Article

Proteasome inhibitors remarkably prevent translesion replication in cancer cells but not normal cellsTAKEZAWA, Jun; ISHIMI, Yukio; YAMADA, Kouichi et al.Cancer science. 2008, Vol 99, Num 5, pp 863-871, issn 1347-9032, 9 p.Article

Downregulation of MMP-2 and -9 by Proteasome Inhibition : A Possible Mechanism to Decrease LEC Migration and Prevent Posterior Capsular OpacificationAWASTHI, Niranjan; WANG-SU, Shuh Tuan; WAGNER, B. J et al.Investigative ophthalmology & visual science. 2008, Vol 49, Num 5, pp 1998-2003, issn 0146-0404, 6 p.Article

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapyDICK, Lawrence R; FLEMING, Paul E.Drug discovery today. 2010, Vol 15, Num 5-6, pp 243-249, issn 1359-6446, 7 p.Article

A mechanistic and kinetic study of the p-lactone hydrolysis of salinosporamide A (NPI-0052), a novel proteasome inhibitorDENORA, Nunzio; POTTS, Barbara C. M; STELLA, Valentino J et al.Journal of pharmaceutical sciences. 2007, Vol 96, Num 8, pp 2037-2047, issn 0022-3549, 11 p.Article

Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesisOLIVA, Joan; FRENCH, Samuel W; JUN LI et al.Experimental and molecular pathology. 2012, Vol 93, Num 1, pp 26-34, issn 0014-4800, 9 p.Article

  • Page / 37